Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites (original) (raw)

References

1. Reiner, S.L. & Locksley, R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151–177 (1995).
   Article CAS Google Scholar
2. Sacks, D.L. & Noben-Trauth, N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845–858 (2002).
   Article CAS Google Scholar
3. Afonso, L.C. et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235–237 (1994).
   Article CAS Google Scholar
4. Gurunathan, S., Prussin, C., Sacks, D.L. & Seder, R.A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4, 1409–1415 (1998).
   Article CAS Google Scholar
5. Gurunathan, S., Klinman, D.M. & Seder, R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18, 927–974 (2000).
   Article CAS Google Scholar
6. Gicheru, M.M. et al. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect. Immun. 69, 245–251 (2001).
   Article CAS Google Scholar
7. Rhee, E.G. et al. Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J. Exp. Med. 195, 1565–1573 (2002).
   Article CAS Google Scholar
8. Desjeux, P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14, 417–423 (1996).
   Article CAS Google Scholar
9. Uzonna, J.E., Wei, G., Yurkowski, D. & Bretscher, P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167, 6967–6974 (2001).
   Article CAS Google Scholar
10. Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M. & Sacks, D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507 (2002).
    Article CAS Google Scholar
11. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712. (1999).
    Article CAS Google Scholar
12. Masopust, D., Vezys, V., Marzo, A.L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413–2417 (2001).
    Article CAS Google Scholar
13. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101–105 (2001).
    Article CAS Google Scholar
14. Roman, E. et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196, 957–968 (2002).
    Article CAS Google Scholar
15. Seder, R.A. & Ahmed, R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4, 835–842 (2003).
    Article CAS Google Scholar
16. Kaech, S.M., Hemby, S., Kersh, E. & Ahmed, R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837–851 (2002).
    Article CAS Google Scholar
17. Wherry, E.J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225–234 (2003).
    Article CAS Google Scholar
18. Bradley, L.M., Watson, S.R. & Swain, S.L. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180, 2401–2406 (1994).
    Article CAS Google Scholar
19. Jung, T.M., Gallatin, W.M., Weissman, I.L. & Dailey, M.O. Down-regulation of homing receptors after T cell activation. J. Immunol. 141, 4110–4117 (1988).
    CAS PubMed Google Scholar
20. Picker, L.J. et al. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J. Immunol. 145, 3247–3255 (1990).
    CAS PubMed Google Scholar
21. Zaph, C. & Scott, P. Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins. J. Immunol. 171, 4726–4732 (2003).
    Article CAS Google Scholar
22. Titus, R.G., Gueiros-Filho, F.J., de Freitas, L.A. & Beverley, S.M. Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92, 10267–10271 (1995).
    Article CAS Google Scholar
23. Brodskyn, C., Beverley, S.M. & Titus, R.G. Virulent or avirulent (dhfr-ts −) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro. Clin. Exp. Immunol. 119, 299–304 (2000).
    Article CAS Google Scholar
24. Mocci, S. & Coffman, R.L. Induction of a Th2 population from a polarized _Leishmania_-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154, 3779–3787 (1995).
    CAS PubMed Google Scholar
25. Mocci, S. & Coffman, R.L. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized _Leishmania major_-specific T cell populations. J. Immunol. 158, 1559–1564 (1997).
    CAS PubMed Google Scholar
26. Iezzi, G., Scheidegger, D. & Lanzavecchia, A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193, 987–993. (2001).
    Article CAS Google Scholar
27. Wang, X. & Mosmann, T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells. J. Exp. Med. 194, 1069–1080 (2001).
    Article CAS Google Scholar
28. Lanzavecchia, A. & Sallusto, F. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2, 982–987 (2002).
    Article CAS Google Scholar
29. Doyle, A.M. et al. Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells. J. Exp. Med. 194, 893–902 (2001).
    Article CAS Google Scholar
30. Gray, D. A role for antigen in the maintenance of immunological memory. Nat. Rev. Immunol. 2, 60–65 (2002).
    Article CAS Google Scholar
31. Zinkernagel, R.M. On natural and artificial vaccinations. Annu. Rev. Immunol. 21, 515–546 (2003).
    Article CAS Google Scholar
32. Swain, S.L., Hu, H. & Huston, G. Class II-independent generation of CD4 memory T cells from effectors. Science 286, 1381–1383 (1999).
    Article CAS Google Scholar
33. Murali-Krishna, K. et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 1377–1381 (1999).
    Article CAS Google Scholar
34. London, C.A., Perez, V.L. & Abbas, A.K. Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo. J. Immunol. 162, 766–773 (1999).
    CAS PubMed Google Scholar
35. Bunce, C. & Bell, E.B. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J. Exp. Med. 185, 767–776 (1997).
    Article CAS Google Scholar
36. Garcia, S., DiSanto, J. & Stockinger, B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 11, 163–171 (1999).
    Article CAS Google Scholar
37. Harbertson, J., Biederman, E., Bennett, K.E., Kondrack, R.M. & Bradley, L.M. Withdrawal of stimulation may initiate the transition of effector to memory CD4 cells. J. Immunol. 168, 1095–1102 (2002).
    Article CAS Google Scholar
38. Flynn, J.L. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb.) 84, 93–101 (2004).
    Article Google Scholar
39. Desrosiers, R.C. Prospects for an AIDS vaccine. Nat. Med. 10, 221–223 (2004).
    Article CAS Google Scholar
40. Scott, P., Pearce, E., Natovitz, P. & Sher, A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139, 221–227 (1987).
    CAS PubMed Google Scholar
41. Lyons, A.B. & Parish, C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131–137 (1994).
    Article CAS Google Scholar

Download references